- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.2: 3 residues within 4Å:- Chain A: N.28, A.29, T.30
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:N.28, A:T.30, A:T.30
- Water bridges: A:E.31
NAG.3: 1 residues within 4Å:- Chain A: N.231
No protein-ligand interaction detected (PLIP)NAG.18: 3 residues within 4Å:- Chain C: N.28, A.29, T.30
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:N.28, C:T.30, C:T.30
- Water bridges: C:E.31
NAG.19: 1 residues within 4Å:- Chain C: N.231
No protein-ligand interaction detected (PLIP)NAG.34: 3 residues within 4Å:- Chain E: N.28, A.29, T.30
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:N.28, E:T.30, E:T.30
- Water bridges: E:E.31
NAG.35: 1 residues within 4Å:- Chain E: N.231
No protein-ligand interaction detected (PLIP)- 39 x SO4: SULFATE ION(Non-functional Binders)
SO4.4: 4 residues within 4Å:- Chain A: S.118, G.119, I.120, N.146
Ligand excluded by PLIPSO4.5: 3 residues within 4Å:- Chain A: N.37, V.38, P.39
Ligand excluded by PLIPSO4.6: 1 residues within 4Å:- Chain A: R.35
Ligand excluded by PLIPSO4.7: 3 residues within 4Å:- Chain A: V.38, P.39, R.40
Ligand excluded by PLIPSO4.8: 3 residues within 4Å:- Chain A: S.84, D.85, V.86
Ligand excluded by PLIPSO4.9: 3 residues within 4Å:- Chain A: T.162, R.163, K.164
Ligand excluded by PLIPSO4.10: 4 residues within 4Å:- Chain A: K.110, E.111, T.112, R.247
Ligand excluded by PLIPSO4.11: 4 residues within 4Å:- Chain A: F.92, V.93, N.94, E.95
Ligand excluded by PLIPSO4.12: 5 residues within 4Å:- Chain A: T.20, E.21, R.22
- Chain F: G.50, N.53
Ligand excluded by PLIPSO4.13: 3 residues within 4Å:- Chain A: T.126, S.127, Q.217
Ligand excluded by PLIPSO4.14: 4 residues within 4Å:- Chain B: W.14, E.15, G.16, R.25
Ligand excluded by PLIPSO4.15: 5 residues within 4Å:- Chain B: F.70, T.71, E.72
- Chain E: N.199, N.229
Ligand excluded by PLIPSO4.16: 5 residues within 4Å:- Chain A: Q.302
- Chain B: E.90, S.93, Y.94
- Chain F: T.59
Ligand excluded by PLIPSO4.20: 4 residues within 4Å:- Chain C: S.118, G.119, I.120, N.146
Ligand excluded by PLIPSO4.21: 3 residues within 4Å:- Chain C: N.37, V.38, P.39
Ligand excluded by PLIPSO4.22: 1 residues within 4Å:- Chain C: R.35
Ligand excluded by PLIPSO4.23: 3 residues within 4Å:- Chain C: V.38, P.39, R.40
Ligand excluded by PLIPSO4.24: 3 residues within 4Å:- Chain C: S.84, D.85, V.86
Ligand excluded by PLIPSO4.25: 3 residues within 4Å:- Chain C: T.162, R.163, K.164
Ligand excluded by PLIPSO4.26: 4 residues within 4Å:- Chain C: K.110, E.111, T.112, R.247
Ligand excluded by PLIPSO4.27: 4 residues within 4Å:- Chain C: F.92, V.93, N.94, E.95
Ligand excluded by PLIPSO4.28: 5 residues within 4Å:- Chain B: G.50, N.53
- Chain C: T.20, E.21, R.22
Ligand excluded by PLIPSO4.29: 3 residues within 4Å:- Chain C: T.126, S.127, Q.217
Ligand excluded by PLIPSO4.30: 4 residues within 4Å:- Chain D: W.14, E.15, G.16, R.25
Ligand excluded by PLIPSO4.31: 5 residues within 4Å:- Chain A: N.199, N.229
- Chain D: F.70, T.71, E.72
Ligand excluded by PLIPSO4.32: 5 residues within 4Å:- Chain B: T.59
- Chain C: Q.302
- Chain D: E.90, S.93, Y.94
Ligand excluded by PLIPSO4.36: 4 residues within 4Å:- Chain E: S.118, G.119, I.120, N.146
Ligand excluded by PLIPSO4.37: 3 residues within 4Å:- Chain E: N.37, V.38, P.39
Ligand excluded by PLIPSO4.38: 1 residues within 4Å:- Chain E: R.35
Ligand excluded by PLIPSO4.39: 3 residues within 4Å:- Chain E: V.38, P.39, R.40
Ligand excluded by PLIPSO4.40: 3 residues within 4Å:- Chain E: S.84, D.85, V.86
Ligand excluded by PLIPSO4.41: 3 residues within 4Å:- Chain E: T.162, R.163, K.164
Ligand excluded by PLIPSO4.42: 4 residues within 4Å:- Chain E: K.110, E.111, T.112, R.247
Ligand excluded by PLIPSO4.43: 4 residues within 4Å:- Chain E: F.92, V.93, N.94, E.95
Ligand excluded by PLIPSO4.44: 5 residues within 4Å:- Chain D: G.50, N.53
- Chain E: T.20, E.21, R.22
Ligand excluded by PLIPSO4.45: 3 residues within 4Å:- Chain E: T.126, S.127, Q.217
Ligand excluded by PLIPSO4.46: 4 residues within 4Å:- Chain F: W.14, E.15, G.16, R.25
Ligand excluded by PLIPSO4.47: 5 residues within 4Å:- Chain C: N.199, N.229
- Chain F: F.70, T.71, E.72
Ligand excluded by PLIPSO4.48: 5 residues within 4Å:- Chain D: T.59
- Chain E: Q.302
- Chain F: E.90, S.93, Y.94
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xiong, X. et al., Receptor Binding by an H7N9 Influenza Virus from Humans. Nature (2013)
- Release Date
- 2013-07-03
- Peptides
- HEMAGGLUTININ: ACE
HEMAGGLUTININ: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 39 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xiong, X. et al., Receptor Binding by an H7N9 Influenza Virus from Humans. Nature (2013)
- Release Date
- 2013-07-03
- Peptides
- HEMAGGLUTININ: ACE
HEMAGGLUTININ: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B